PC CTP 2015

Prof Peter Mulders, Prof Axel S. Merseburger, Prof Pablo Maroto, Prof Peter Iversen Prof Merseburger (Hannover Medical School, Hannover, Germany) chairs a discussion for ecancertv in Baveno, Italy, with Prof Maroto (Autonomous University of Barcelona, Barcelona, Spain), Prof Mulders (Radboud University, Nijmegen, Netherlands), and Prof Iversen (Copenhagen Prostate Cancer Center, Copenhagen, Denmark) about advances in prostate cancer treatment. They discuss the treatment of castration-resistant prostate cancer (CRPC) and the way it is defined. They contemplate the importance of the placement of chemotherapy in the treatment sequence, as well as the role of androgen deprivation therapy (ADT) and the possibility of screening for predictive markers.

Prof Axel S. Merseburger and Prof Romano Danesi Prof Merseburger (Hannover Medical School, Hannover, Germany) and Prof Danesi (University of Pisa, Pisa, Italy) discuss the latest in prostate cancer treatment at the treatment practice meeting in Baveno, Italy, for ecancertv. In particular, they focus on pharmacokinetics and the complex nature of absorption and inhibition.